Studies have demonstrated that PRNP modulates the expression of MAPK and FOXO3a via the epidermal growth factor receptor signaling pathway (15), influencing the emergence of platinum resistance in colorectal cancer. This evidence concerns the gene EGFR and colorectal cancer.